These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 824553)

  • 1. [Combination of physiotherapeutic exercise therapy with bencyclane in intermittent claudication (author's transl)].
    Krause D; Dittmar K
    MMW Munch Med Wochenschr; 1976 Oct; 118(40):1281-4. PubMed ID: 824553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Active therapeutic exercises in combination with vasoactive drug in intermittent claudication (author's transl)].
    Krause D; Dittmar K
    MMW Munch Med Wochenschr; 1978 Jan; 120(2-3):69-72. PubMed ID: 414129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Success of physiotherapeutic interval training combined with standardized hemoderivative in intermittent claudication (author's transl)].
    Dittmar K; Krause D
    MMW Munch Med Wochenschr; 1977 Mar; 119(11):369-72. PubMed ID: 403421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic arterial insufficiency of lower limbs: treatment by bencyclan (fludilat) (author's transl)].
    Krähenbühl B
    Schweiz Rundsch Med Prax; 1975 May; 64(20):632-4. PubMed ID: 1099573
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of arterial occlusive diseases. The effect of bencyclan in trained patients with peripheral arterial occlusive disease (Double-blind study)].
    Battke K; Buchwalsky R; Barmeyer J; Hoffmann G; Reindell H
    Fortschr Med; 1978 Jul; 96(26-27):1381-6. PubMed ID: 669532
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bencyclan (Fludilat) in the treatment of patients with ischaemic cerebral infarction (author's transl)].
    Schneider E; Fischer PA; Jacobi P
    Med Klin; 1976 Sep; 71(39):1611-6. PubMed ID: 790129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Circulation disorders: tested drug therapy].
    MMW Munch Med Wochenschr; 1980 Nov; 122(45):55, 57. PubMed ID: 6779131
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of oxyfedrine and intervall training in intermittent claudication (author's transl)].
    Cachovan M; de Marées H; Kunitsch G
    Z Kardiol; 1978 Apr; 67(4):289-98. PubMed ID: 654412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of blood circulation disorders with a hemoactive-vasoactive drug].
    Aguirre-Contreras JA; Meza y Gutiérrez E
    Prensa Med Mex; 1977; 42(11-12):509-15. PubMed ID: 351601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of disorders of cerebral performance in the aged in ambulatory care using bencyclane. Results of a controlled double-blind phase III study versus placebo].
    Garweg G; Herrmann WM; Kern U
    Z Gerontol; 1987; 20(1):56-62. PubMed ID: 3554804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Important prognostic factors for the results of physiotherapeutic exercises in intermittent claudication (author's transl)].
    Krause D; Stang A; Zezschwitz W
    MMW Munch Med Wochenschr; 1977 Oct; 119(40):1289-94. PubMed ID: 412058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
    Messa GL; Gelso E
    Drugs Exp Clin Res; 2002; 28(1):37-48. PubMed ID: 12073766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Demonstration of bencyclane effects in a clinico-pharmacologic vigilance model].
    Herrmann WM; Kern U
    Z Gerontol; 1984; 17(5):261-70. PubMed ID: 6395526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of the physiotherapy of arterial disease at the stage of intermittent claudication by programmed efforts training (author's transl)].
    Franco A; Legrand E; Guidicelli H; Quesada C; Sarrazin R; Gautier R
    J Mal Vasc; 1980; 5(3):185-9. PubMed ID: 7462850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PoleStriding exercise and vitamin E for management of peripheral vascular disease.
    Collins EG; Edwin Langbein W; Orebaugh C; Bammert C; Hanson K; Reda D; Edwards LC; Littooy FN
    Med Sci Sports Exerc; 2003 Mar; 35(3):384-93. PubMed ID: 12618567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new drug in the treatment of chronic arterial diseases of the limbs].
    Schmidt C; Royer RJ; Schmitt J
    Sem Hop; 1978 Feb; 54(4):210-3. PubMed ID: 208169
    [No Abstract]   [Full Text] [Related]  

  • 17. The novel phosphodiesterase inhibitor NM-702 improves claudication-limited exercise performance in patients with peripheral arterial disease.
    Brass EP; Anthony R; Cobb FR; Koda I; Jiao J; Hiatt WR
    J Am Coll Cardiol; 2006 Dec; 48(12):2539-45. PubMed ID: 17174195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fludilat treatment of vagotonic and subendocardial disturbances of cardiac metabolism and bradycardiac coronary diseases (author's transl)].
    Széplaki S; Széplaki Z
    MMW Munch Med Wochenschr; 1976 Mar; 118(10):309-12. PubMed ID: 817154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E; Bahnini A; Mouren X; Gamand S
    Int Angiol; 2001 Mar; 20(1):58-65. PubMed ID: 11342997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of fludilat in cerebrovascular insufficiency].
    García Guerra CM
    Prensa Med Mex; 1977; 42(11-12):504-8. PubMed ID: 351600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.